Drug Trial Radar · NCT00003088
Combination Chemotherapy in Treating Patients With Breast Cancer
Last checked: Nov 20, 2026Latest source record: Apr 29, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,005
Actual
Start
Sep 1997
Primary completion
Apr 2003
Study completion Jun 2003
Sponsor
- Lead sponsor
- Alliance for Clinical Trials in OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Sep 6, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs at different times or combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy consisting of either doxorubicin, cyclophosphamide, or paclitaxel given at different times with that of combination chemotherapy consisting of doxorubicin plus cyclophosphamide followed by paclitaxel in treating women with stage II or stage IIIA breast cancer.
Conditions
- Breast Cancer
Interventions
cyclophosphamideDrug
given IV
doxorubicin hydrochlorideDrug
given IV
paclitaxelDrug
given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease free survivalTime frame: 4 years
Locations
19 sites in 2 countries. Site status is shown where the registry gives one.
CCOP - Scottsdale Oncology Program
Scottsdale, Arizona
CCOP - Illinois Oncology Research Association
Peoria, Illinois
CCOP - Carle Cancer Center
Urbana, Illinois
CCOP - Cedar Rapids Oncology Project
Cedar Rapids, Iowa
CCOP - Iowa Oncology Research Association
Des Moines, Iowa
Siouxland Hematology-Oncology
Sioux City, Iowa
CCOP - Ochsner
New Orleans, Louisiana
CCOP - Ann Arbor Regional
Ann Arbor, Michigan
CCOP - Duluth
Duluth, Minnesota
Mayo Clinic Cancer Center
Rochester, Minnesota
CentraCare Clinic
Saint Cloud, Minnesota
CCOP - Missouri Valley Cancer Consortium
Omaha, Nebraska
Quain & Ramstad Clinic, P.C.
Bismarck, North Dakota
CCOP - Merit Care Hospital
Fargo, North Dakota
Altru Health Systems
Grand Forks, North Dakota
CCOP - Toledo Community Hospital Oncology Program
Toledo, Ohio
Rapid City Regional Hospital
Rapid City, South Dakota
CCOP - Sioux Community Cancer Consortium
Sioux Falls, South Dakota
Saskatchewan Cancer Agency
Regina, Saskatchewan, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.